Merck, Johnson & Johnson CEOs will testify on high drug prices


The CEOs of Merck and Johnson & Johnson have agreed to testify before the Senate health committee voluntarily, avoiding a subpoena threat. This decision came after pressure from Bernie Sanders to discuss why drug prices in the United States are higher than in other countries. Sanders had planned to subpoena the CEOs, but they agreed to testify voluntarily. Sanders expressed his delight that the CEOs will be appearing before the committee without the need for a subpoena. This reflects a last resort effort to get the CEOs to testify. The hearing will hopefully shed light on the reasons behind high drug prices in the US.

Source link

error: Content is protected !!